CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...